Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
0.9277
-0.0023 (-0.25%)
At close: Sep 11, 2026, 4:00 PM EDT
0.9300
+0.0023 (0.25%)
After-hours: Sep 11, 2026, 7:58 PM EDT
Canopy Growth Revenue
Canopy Growth had revenue of 81.17M CAD in the quarter ending June 30, 2026, with 12.52% growth. This brings the company's revenue in the last twelve months to 293.63M, up 6.81% year-over-year. In the fiscal year ending March 31, 2026, Canopy Growth had annual revenue of 284.60M with 5.80% growth.
Revenue (ttm)
293.63M CAD
Revenue Growth
+6.81%
P/S Ratio
1.89
Revenue / Employee
260,314 CAD
Employees
1,128
Market Cap
390.33M USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 284.60M | 15.61M | 5.80% |
| Mar 31, 2025 | 269.00M | -28.15M | -9.47% |
| Mar 31, 2024 | 297.15M | -36.11M | -10.83% |
| Mar 31, 2023 | 333.25M | -142.45M | -29.94% |
| Mar 31, 2022 | 475.70M | -70.95M | -12.98% |
| Mar 31, 2021 | 546.65M | 147.88M | 37.08% |
| Mar 31, 2020 | 398.77M | 172.43M | 76.18% |
| Mar 31, 2019 | 226.34M | 148.39M | 190.37% |
| Mar 31, 2018 | 77.95M | 38.05M | 95.38% |
| Mar 31, 2017 | 39.90M | 27.20M | 214.16% |
| Mar 31, 2016 | 12.70M | 10.33M | 435.60% |
| Mar 31, 2015 | 2.37M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Tilray Brands | 915.45M |
| Evotec SE | 819.47M |
| Emergent BioSolutions | 770.20M |
| Evolus | 316.49M |
| Akebia Therapeutics | 219.06M |
| Kamada | 191.85M |
| Anika Therapeutics | 120.65M |
| Aquestive Therapeutics | 54.09M |
CGC News
- 4 days ago - Canopy Growth broadens medical cannabis portfolio in Australia - TheFly
- 4 days ago - Canopy Growth Broadens Australian Medical Cannabis Portfolio With New Formats and Formulations - Business Wire
- 5 days ago - Canopy Growth's Revenue Grew 13% Last Quarter. Investors Barely Reacted. - The Motley Fool
- 7 days ago - Should You Buy Canopy Growth Stock on the Rebound? - The Motley Fool
- 10 days ago - Better Cannabis Stock to Buy Right Now: Canopy Growth or Tilray Brands? - The Motley Fool
- 11 days ago - 3 Top Marijuana Stocks to Watch in September 2026 - MarijuanaStocks
- 25 days ago - Top Canadian Cannabis Stocks to Watch in August 2026 - MarijuanaStocks
- 26 days ago - Canopy Growth Proxy statement: Proxy filing - Filings